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INTRODUCTION
This proposal entitled "Effects of moderate aerobic exercise combined with caloric restriction on circulating estrogens and IGF-I in premenopausal women" was designed to provide important scientific contributions with respect to the primary prevention of breast cancer in women. Specifically, this study examined potential mechanisms relating to the role of physical activity in the reduction of the risk of breast cancer by experimentally testing whether moderate aerobic exercise can reduced the levels of two hormonal biomarkers, circulating estrogens and insulin-like growth factor I (IGF-I). Since elevated levels of both of these hormones have been associated with an increased risk of breast cancer, and because exercise and weight loss has been shown to induce disturbances in menstrual cyclicity that may reduce circulating estrogens, we wished to extend previous findings from epidemiological and cross-sectional studies by performing a tightly controlled, prospective clinical study that addressed previously unanswered questions related to the role of exercise in the modulation of estrogen and IGF-I. Although previous studies have shown that negative energy balance, and not other stressful aspects of physical exercise, can modulate reproductive function and reduce circulating estrogen levels, no studies to date have determined the magnitude of energy deficit required for these changes during long-term training, and no studies have attempted to differentiate between the exercise-induced changes in ovarian versus adipose sources of circulating estrogens. Since both estradiol (ovarian) and estrone (adipose tissue) are biologically active, and because the importance of estrone as a risk factor increases with age and adiposity, it is important to consider the degree to which exercise which creates a negative energy balance affects both of these sources of circulating estrogens.
Circulating levels of IGF-I correlate with breast cancer risk, yet studies examining the responses of this hormone and its binding proteins to chronic exercise are lacking. Since IGF-I levels are very sensitive to nutritional status, previously reported stimulatory effects of exercise on IGF-I can be overridden if exercise is performed in the face of negative energy balance. In this regard, exercise that promotes weight loss can be viewed as a way to reduce levels of IGF-I, and therefore potentially reduce the risk of breast cancers. To date, no studies have addressed whether a program of moderate aerobic exercise and dietary restriction producing a negative energy balance that is carried out over a long duration will significantly alter IGF-I levels. Further, the degree to which these levels might be altered in individuals of differing initial energy stores has not been addressed.
Metabolic energy availability is an important contributing factor in the development of reproductive cancers. However, current methods for assessing energy availability, which include anthropometric measures, calculations of energy balance, evaluation of various serum and urinary biomarkers are prone to measurement error, not sensitive to alterations in energy availability, and are sometimes affected by disease states. The current project includes an introduction of a novel approach to estimating energy status by measuring metabolic hormones in plasma, T3, IGF-I and leptin. Recently, dried blood spot (DBS) sample collection techniques have allowed for endocrine based population studies examining a wide variety of ecological factors that contribute to variation in human reproduction. In order to use the proposed method of energy status assessment in large population-based applications, such as those addressing the role of physical activity and or diet in the risk of breast cancer, the battery of metabolic hormones that comprise the proposed method must be amenable to collection and assays. Although the DBS technique has been partially validated for some hormonal assays, it has not yet been properly validated for T3, IGF-I, and leptin, and it is unclear whether the technique is responsive to physiological changes of these compounds. Therefore, the current work calls for the validation of the DBS sampling technique for these assays under physiological conditions.
The proposed studies will yield new and important information regarding the degree to which an exercise and diet program that results in an energy deficit will reduce the risk of breast cancer.
BODY
Study Design: The study utilized a prospective, randomized design that tested the effects of a moderate exercise program (4X/wk; 4 months) combined with moderate dietary restriction that results in an average daily energy deficit of -20%-40% kcals (Figure 1) . Previously sedentary, eumenorrheic women aged 25-40 years were assigned to exercise or light conditioning groups. Initially, we had targeted both normal weight (BMI 21-25 kg/m 2 ) and overweight (BMI 26-30 kg/m 2 ) women to be assigned to either the Exercise (exercise 4 X per week; 20-30% dietary restriction) or Light Conditioning groups (exercise 2X/wk; no dietary restriction) groups; 4 groups, n=15 each group. Subjects were studied for a total of six menstrual cycles, i.e., 2 control followed by 4 cycles with training and dietary restriction. (Days 3, 6, 8, 10, 12, 14 , 16, 19, 22, & 25 (Days 3, 6, 8, 10, 12, 14 , 16, 19, 22, & 25 (See previous Annual Summary for [2003] [2004] **************************************************************************** Proposed Months 38-42, October, 2004 -February, 2005 • Requested extension for final report for this study (IDEA Award) from DAMD;
Recruiting/ Screening
• Perform urinary LH, E1G, and PDG assays, and serum metabolic assays when final cohort is finished;
• Perform insulin, IGFBP-2, estradiol, and estrone on remaining completed subjects;
• Send completed DBS samples from completed subjects to Salimetrics • Perform data analysis;
• Obtain results of DBS samples from Salimetrics, • Submit abstract for ERA of HOPE Meeting in December, 2004 Actual Months 38-42, October, 2004 -February, 2005 • Extension requested and granted for final report for this study (IDEA Award); We are unclear why another request for a Final Report was made in October of 2005.
• Urinary assays for LH, E1G, and PdG assays from 47 subjects were performed during February -March of 2005.
• Assays for estrone, estradiol, and insulin-life growth factor - 
Report of Final Results:
Subject Recruitment:
Over the three years in which the study took place, 572 contacts through phone or email were made with women interested in the study. Of those 572 women, 85 signed informed consents for the study, 52 were excluded from the study at various time points for the following reasons: 10 for medical reasons, 17 because of time constraints or other personal reasons, 3 became pregnant during the study, 1 had abnormal prolactin levels, 6 exceeded limits for body composition or body weight, 2 dropped out because they were not able to receive financial compensation due to visa restrictions, 11 had existing menstrual abnormalities, and 2 were asked to leave because of non-compliance. Forty seven women began the experimental protocol (Table 1 ). There were 33 women who completed the study ( 
Dietary Intake during the Intervention:
The target macronutrient composition for all subjects during the intervention was 55% carbohydrate, 30% fat, and 15% protein. Using the average total daily caloric intake from the each subject's three day diet log, in combination with the Harris Benedict equation as adjusted for daily physical activity (Harris et al.,1919) , an estimate of the eucaloric (weight maintenance) energy needs of each subject were calculated. In order to promote weight loss, this level of dietary intake was reduced by 20-30 % for exercising subjects, and this new level was their target daily caloric intake throughout the intervention. For light conditioning subjects, the target level of daily dietary intake during the intervention remained that which represented their eucaloric energy needs. Prior to the intervention the GCRC dietician taught all subjects how to use the food exchange system (American Diabetes Association, 2003 Edition, Chicago, IL) to obtain their targeted caloric intake, and the targeted macronutrient composition. Subjects kept track of their daily food exchanges by recording them on monitoring forms for seven days at a time, every two weeks. Estimates of daily caloric intake from food exchange monitoring sheets were determined using Dietician's Assistant v. 2.99 (Compu-Cal Inc., Olympia, WA). Once per menstrual cycle during the intervention subjects also completed a 3 day diet log. Total calories and macronutrient content was determined using Nutritionist Pro (First Data Bank, Indianapolis, IN). If difficulties arose with subjects meeting their targeted caloric intake, the dietician counseled on how to overcome these challenges. If subjects in the Light Conditioning group were experiencing weight changes, or if subjects in the Exercise group were not losing weight, appropriate changes to the target caloric intake were made. Dietary counseling sessions for both Light Conditioning and Exercise groups included discussion of food education modules including Shopping Tips, Low Fat/Low Calorie food, Food Preparation, Dining Out, Iron, Calcium, Fiber, and Vitamins in Food.
Exercise Training During the Intervention
Subjects in both groups attended supervised exercise sessions in the training room in Noll Laboratory that were monitored by a Head Trainer and several personal trainers who had experience in fitness assessment and personal training. Workouts for the exercise group were four times per week and consisted of a 5 minute warm-up followed by approximately 40-90 min of aerobic activity at a heart rate 60-90% (average 79 ± 0.7/ 6.0 % (sem/SD)) of the maximal heart rate (obtained from the VO 2 max test achieved during exercise sessions), followed by a 10 min cool-down. Modes of aerobic activity included treadmill walking, stationary cycling, and stair stepping. Average attendance for subjects in the Exercise group was 96 + 0.9/4.6 (sem/sd) % of the total workouts. The duration of exercise for the Exercise group was equal in minutes to that required to expend a target amount of calories, determined to be approximately 20% of the subjects' eucaloric intake. For example, if the pre-determined eucaloric intake was 2000 calories, then this subject's exercise calorie target would be 400 calories. The total amount of calories expended during each exercise session was measured using the OwnCal feature on the Polar S610 heart rate monitor (Polar Electro Oy, Kempele, Finland). Throughout the study the heart rate monitors were continually reinitialized with the most recent values of weight, maximum heart rate, maximal aerobic capacity, and age.
Light conditioning subjects exercised 2 times per week; sessions were comprised of 36 + 2.9/8.3 (sem/sd) minutes of aerobic activity at 77 + 0.8/2.3% (sem/sd) of maximum heart rate, and 10 minutes of light stretching and calisthenics. Compliance to these sessions was 94 %. These sessions were designed to provide a sufficient training stimulus for subjects to see some improvement in aerobic capacity and strength and flexibility, but not to expend a significant amount of calories such that weight loss would be observed. Earlier attempts at recruiting subjects who would agree to be randomized to a non-exercising control group were unsuccessful.
Results for Body Weight and Body Composition
Descriptive characteristics for completed subjects are presented in Table 2 . No differences were observed in any of the parameters after women were randomized to Light Conditioning versus the Exercise groups with the exception of age (P= 0.049; independent t-test). Light Conditioning women were significantly older when compared to the exercise women.
The effects of the intervention on body composition, body weight, and fitness are shown in Table 3 . More detailed effects of the intervention on body weight are shown in Figure2. In general significant improvements were observed in all variables over the course of the intervention, with the exception of no change in fat free mass. Significant group interactions were observed for all variables where significant changes occurred over time, except VO 2max , indicating that although changes were favorable in both groups, the Exercise group exhibited significantly greater gains as a result of the intervention. Average percent changes from baseline for VO 2 max for Light Conditioning and Exercise groups respectively were +30 ±5%, and +27 ± 5%. Average percent changes from baseline for percent body fat for Light Conditioning and Exercise groups respectively were -3.8 ±1.7 %, and -15 ± 2.3%. Light Conditioning subjects lost 1.2 ± 0.6 % of their initial body weight, while Exercise subjects lost 6.0 ± 0.9%. Daily caloric intake from the average of three day diet logs recorded during the baseline period, and during the fourth menstrual cycle exhibited a significant decrease over time (P<0.001), and this difference varied between the Light Conditioning and Exercise groups (interaction effect P = 0.004) such that the Exercise group experienced a 32% decrease and the Light Conditioning group experienced an 8% decrease. Average macronutrient content across the intervention was not different between groups with the exception of the percent of daily calories derived from fat. Light Conditioning subjects consumed 34.8 ± 4.5 % fat versus the Exercisers who consumed 27.5 ± 5.2 % (P = 0.035; one -way ANOVA on average 3 day diet macronutrients for Exercise 1, Exercise 2, and Exercise 3, and Exercise 4 
Results for Serum Estradiol and Urinary Estrogen (E1G)
A composite graph of changes across the menstrual cycle in serum estradiol, depicted according to cycle day at baseline and during the fourth intervention month is depicted in Figures 3 and 4 . Average serum estradiol for the Control Cycle 2 and the Exercise 4 cycle are shown in Figure 5 . When serum measurements of estradiol are examined across Control Cycle 2 (n=10 measurements per subject), and Exercise 4 cycles (n=10 measurements per subject) are averaged, and then compared with paired samples T-tests, no differences are observed in either the light conditioning (p = 0.43) or exercising groups (p=0.32), despite the loss of body fat. Changes in average urinary E1G in both experimental groups are depicted in Figure 6 . There are no significant effects of time or group on urinary E1G (ANOVA with repeated measures, time effect p= 0.15; group effect p = 0.23), despite the significant loss of body weight and body fat. With respect to estrone, Figure 7 illustrates the close correlation between urinary E1G, serum estradiol, and serum estrone in a representative subject. Similar results were obtained for all other subjects, illustrating that serum estrone concentrations in premenopausal women are of ovarian origin versus peripheral production in adipose tissue. Figure 8 illustrates the changes in serum estrone in exercising subjects. There were no significant effects of the intervention on these levels (paired t-test: p=0.689). Results for IGF-1: Figure 9 illustrates the changes in IGF-1 across the intervention. IGF-1 does not decline despite significant fat and weight loss in Exercise or Light Conditioning (ANOVA with repeated measures, time effect: p = 0.139, group effect p = 0.396), and there is no correlation between change in body weight and change in IGF-1 from pre to post (Linear regression p >0.05; R 2 = 0.002) (Figure 10) . . 
IGF-1 Each Study Phase

Results for Insulin, IGFBP-3, and SHBG:
Additional funding has been secured by the PI to assay these hormones and binding proteins during the Spring of '07 in her laboratory at PSU. Currently there are no data for these analytes. The final report mistakenly listed insulin assays as having been completed.
Results for Dried Blood Spot Samples:
Samples for serum versus dried blood spot analyses were analyzed in the PI's lab (serum hormone concentrations) or by Salimetrics, Inc., Penn State University (Blood Spot assays). Results for the comparison between serum and dried blood spot samples are illustrated in Tables 4, 5, and 6, and Figures 9, 10, and 11 . Leptin venipuncture concentrations were significantly correlated with leptin dried blood spots concentrations (R = 0.677; p = 0.011). Results for T3 indicated no correlation between serum and blood spot values (R= 0.320; p=0.211). IGF-1 venipuncture concentrations were significantly correlated with blood spot values (R= 0.778; p < 0.0001). 
Figure10. Scatterplot of leptin dried blood spot (X axis) vs leptin (Y axis) venipuncture results
Figure11. Scatterplot of dried blood spot T3 (X axis) vs serum T3 (Y axis) venipuncture results
Figure12. Scatterplot of IGF-1 dried blood spot (X-axis) vs IGF-1 venipuncture (Y axis) results
Results of Additional Projects:
Findings from two additional projects using samples and or data from the primary study are reported below.
Additional Project #1: "Effect of Exercise Training on Estrogen Metabolism in Premenopausal Women"
Manuscript #1: In Review in Medicine, Science, Sports and Exercise, Fall, 2006 : Effect of Exercise Training on Estrogen Metabolism in Premenopausal Women. Kim C. Westerlind, Jennifer Bell, Nancy I. Williams This manuscript is in review, written in collaboration with Dr. Kim Westerlind, AMC Cancer Center, Boulder, Colorado. An increasing body of data provides evidence that being physically active reduces a woman's risk for developing breast cancer. To date, the mechanism for this reduction in risk remains unknown. The original study that is the subject of this Final Report was designed to examine how exercise combined with caloric restriction alters circulating estradiol and estrone, and circulating concentrations of IGF-I. Another hypothesis is that exercise may exert more subtle changes in steroid hormone profiles, specifically that exercise may result in an increase in the hydroxylation of the parent estrogens through the 2-hydroxylation pathway with a concomitant decrease through the 16 OHE pathway. Higher levels of 2OHE1 have been associated with decreased breast cancer risk. In animal tumor models, increased 20HE1 results in reduced tumorigenesis. In contrast, 16OHE1 has potent estrogenic effects and has been reported to be elevated in normal and malignant tissue from women with breast cancer. We proposed that exercise increases the ratio of 2/16 OHE1. We reasoned that this in turn might be a factor in the physical activity-mediated reduction in breast cancer risk that has been observed in epidemiological and some animal studies. We sought to examine the effect of exercise training on estrogen metabolism in the same subjects as were used in the current study. We hypothesized that exercise training would result in an increase in the 2/16 ratio.
Urine samples from the mid-follicular (length of follicular phase divided by 2 = day of cycle on which urine sample was analyzed) and mid-luteal phases (length of luteal phase divided by 2 = day of cycle on which urine sample was analyzed) from each cycle from each subject in the study were sent for analysis by Dr. Westerlind. Urine was collected daily by subjects and represented an aliquot from their first morning void. Samples were shipped on dry ice to the AMC Cancer Research Center where they were stored at -80 until all samples from a given subject were available to be assayed. The funds for these assays were awarded from a separate grant that Dr. Westerlind wrote in collaboration with Dr. Williams. Estrogen metabolite levels were measured using a commercially available competitive, solid-phase enzyme-linked immunoassay (ESTRAMET, ImmunaCare, Corp) and the ratio of 2/16 computed. The frozen urine samples were brought to room temperature before testing. Samples were diluted 1:4 prior to testing with manufacturer-supplied diluent. In urine, 2-OHE1 and 16OH are found in the glucuronide conjugate from and require removal of the sugar moiety before recognition by the monoclonal antibodies. Samples are deconjugated with b-glucoronidase and arylsulphatase, then neutralized. Samples are incubated for 3 hrs at room temperature then kinetically read every 2 min for 20 minutes using a Thermomax Microplate Reader (Molecular Devices, Sunnyvale, CA). Estrogen metabolite values were determined from a calibration curve derived from six standards with the kit (0.625 -15.0 ng/ml). All samples, controls, and standards are assayed in triplicate and all of the samples from a given subject were batch assayed to minimize interassay variability. Any sample outside of the range of the standard curve or with a coefficient of variation greater than 10% was reassayed. In house and manufacturersupplied controls were included in each of the assays performed. Urinary 2OHE1 and 16OHE1 were normalized to urinary creatinine concentration and expressed in ng/ml/mg creatinine. When the ratio was computed the values used were uncorrected. Urinary creatinine was measured in duplicate using a Diagnostic Chemicals Limited Assay (company, state). The ratio of 2/16 OHE1 was computed by dividing the absolute concentration of 2OHE1 by 16OHE1. Results were analyzed using SPSS Statistical software, version 13.0. Statistical tests included t-tests and repeated measures ANOVAs or ANCOVAs.
Preliminary results from the analyses of these samples indicate that the ratio of 2/16 was significantly higher in the exercise women (1.96) compared to the controls (1.41) . This was factored into the statistical analyses. Estrogen metabolite values for the subjects overall did not change significantly as a result of the intervention. 2OHE1 and 16OHE were higher during the luteal phase than the follicular phase as would be expected as the concentration of the metabolites parallels the changes in estradiol during the menstrual cycle. The 2/16 ratio was not significantly different between the follicular and luteal phase for any of the months of assessment (P values ranged from 0.30 to 0.99). In order to evaluate the change in 2/16 over time, the percentage change between each of the months of the studies was calculated. Data for the 2/16 were evaluated by calculating the percent change over the course of the intervention programs. 2/16 increased linearly in the follicular phase (p=0.004) but did not differ between groups (p=.91). In the luteal phase, initial 2/16 ratios were lower in the Light Conditioning group (1.41) vs the Exercise group (1.94) (p=0.04). After adjusting for initial differences, significant increases over time were observed (p<0.001) but no difference was observed between groups (P=0.53). Evaluating the data further, we analyzed the relationship between a woman's initial 2/16 values in both the follicular and luteal phases and her exercise-associated changes in 2/16. Correlations between baseline follicular and luteal 2/16 ratios was r = 0.79. Baseline values for 2/16 were significantly associated with the percent change in the ratio over the exercise periods. Most dramatically, the 2/16 ratios in the follicular and luteal phase of the baseline month were correlated r = -0.59 (p=0.002) and r = -0.72 (p<0.001) with the total percent change (defined as the percent change between baseline and the fourth exercise month) in 2/16 luteal phase. When we divided the women into quartiles (n=6/quartile) based on either their baseline follicular or luteal 2/16 ratios with experimental groups combined (Tables 7 and 8) , we observed a significant effect of exercise on the ratio of 2/16. Women within the lowest quartile, i.e., those with the lowest ratio of 2/16, had the largest increase in the ratio in response to exercise. Absolute estrogen metabolite values as well as percentage change over time were not associated with any change in body composition, BMI, or weight. Overall significance determined by ANOVA with post-hoc LSD a significantly different than quartiles 2, 3, and 4 b significantly different than quartile 4
In conclusion, the data suggest that women who have low 2/16 ratios may respond positively to exercise training with an increase in 2/16. Literature suggests that women with low 2/16 ratios may be at higher risk for developing breast cancer. Thus, exercise training may be of significant benefit to reducing breast cancer risk, particularly for those women at greatest risk. This manuscript is in Review in Medicine, Science, Sports, and Exercise. An abstract describing this work was presented at the Although energy deficiency is known to disrupt reproductive function in exercising women, no studies have examined whether the susceptibility to menstrual disturbances is altered with increased age. Therefore, the purpose of this study was to determine whether increased age is associated with reduced susceptibility to menstrual disturbances caused by chronic energy deficiency. A subset of twenty-four premenopausal women (12 young and 12 middle aged) from two larger studies (the DOD study that is the subject of this report, and an NIH funded study examining weight loss effects in younger (18-25 yrs) women) were matched according to the amount weight lost during a three month diet and exercise intervention. Menstrual status was assessed with daily urine samples and measurement of estrogen (E1G) and progesterone (PdG) conjugates using enzymatic immunoassays. The occurrence of menstrual disturbances, i.e., short luteal phases, inadequate luteal phases, oligomenorrheic cycles, and anovulatory cycles was quantified according to the number of defects/number of cycles observed. Independent samples t-tests were conducted to determine if there was a significant difference between younger and older women in the occurrence of menstrual disturbances. In conclusion, older age was associated with significantly fewer disturbances in response to weight loss resulting from a diet and exercise intervention (Table 9 ). These results suggest that factor(s) associated with increased age confer protection against menstrual disturbances caused by energy deficiency. An abstract describing this work was presented at the American College of Sports Medicine, June, 2006 in Boulder, Colorado, and a manuscript is in review:
Susceptibility to energy-related menstrual disturbances is reduced with increased age. Brandy Weller, Ann Albert, Matthew Johnson, Nancy Williams, Penn State University, University Park, PA 16802 Overall Discussion:
The results of this study are unexpected, as it was hypothesized that significant weight loss produced through a combination of diet and exercise would result in significant declines in circulating biomarkers of breast cancer. The results thus far indicate that several measures of estrogens, i.e., serum estradiol spread out across the menstrual cycle, average serum estradiol, urinary metabolites reflecting estradiol (E1G), and serum estrone (E3) do not change with weight loss, despite significant losses of both body weight and body fat. Previous prospective exercise training studies promoting weight loss in younger women age 18-25 yrs (Bullen et al. 1985 have demonstrated significant disturbances in menstrual cyclicity with concomitant changes in measures of estrogens with a range of weight loss that approximates that observed in the current study conducted in older (25-40) women. These results suggest that there is an agerelated decline in the responsiveness of the hypothalamic-pituitary-gonadal axis to an energy imbalance such that age protects against energy perturbations that might compromise reproductive function. This finding is novel. One other study has directly compared the responses to a negative energy balance between young (18-25 yrs) and older (26-30 yr) of the reproductive axis and found that 5 days of low energy availability produced significant decreases in LH pulse frequency only in the younger subjects (Loucks, 2006) . The findings from the the current study extend those of Loucks to the entire menstrual cycle over a prolonged period of energy deficiency. The findings are currently the subject of a manuscript from the PI's laboratory (results reported as Additional Project #2) where young and older subjects were matched for weight loss and other baseline characteristics, and the effects of weight loss over 3 months were directly compared. Data from the DOD funded study are compared to those from an NIH funded study conducted in younger women. This manuscript is in review. The PI also plans to use these data as preliminary data for a NIH grant proposal.
Another unexpected finding is that for IGF-1, which showed no significant changes in response to significant weight loss. We anticipated a reduction in IGF-1, as this hormone is often found to decrease with energy deprivation (Thissen, 1994) . One explanation might be that exercise training, which has been reported to increase with exercise training (Koziris et al., 1999) may have represented a competing influence on IGF-1 production and thus in combination, weight loss and exercise training resulted in no change in IGF-1 levels. We plan to perform further analyses of IGFBP-3 to determine if the bioavailability of IGF-1 was altered with our intervention. This result suggests, that although physical activity has been associated with a reduced risk of breast cancer, reductions in IGF-1 are not likely to be a mechanism for this reduced risk.
A novel and unexpected finding from Additional Project #1 is that the ratio of estrogen metabolites 2OHE1 /16OHE was increased with exercise training in subjects who were ranked in the lowest quartile, those with the lowest ratio of 2/16 . Because this direction of change is associated with a reduced risk of breast cancer, this finding indicates a potential for a beneficial effect of exercise training in breast cancer risk in some subjects when risk is assessed using these estrogen metabolites. Current studies are planned to examine the response of these metabolites in younger women age 18-25 yrs to exercise training associated with weight loss.
Data for the dried blood spot indicate promise with respect to the potential use of dried blood spot assays and collection procedures to assess metabolic hormones and changes in these hormones with weight loss. We found significant correlations between leptin in serum and leptin in blood spots, and between IGF-1 in serum and IGF-1 measured in blood spots. Reasons for the lack of a significant correlation between serum and blood spot T3 are unknown but could be due to problems with the assay or blood collection techniques using filter paper. Future studies might yield a more positive result if trouble-shooting were performed. These results suggest that for IGF-1 and for leptin, field testing for assessment of energy balance is possible using dried blood spot techniques. 
MANUSCRIPTS DURING THE ENTIRE PERIOD OF SUPPORT
